Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $20.15 | $47.32 |
| Change | 0.11 (0.55%) | 0.58 (1.24%) |
| Market Cap | $2.53B | $8.99B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -23.99 | -15.46 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $42.47 | $48.68 |
| 52-Week Low | $16.10 | $21.72 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.80 | $-3.56 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | 13.91% | -33.12% | -46.95% | -40.13% | 43.62% | 43.62% |
| BBIO | 13.40% | 31.15% | 80.68% | 49.13% | 71.76% | 71.76% |